Registry following people treated with neurovascular devices for brain conditions
Follows adults treated with devices for brain aneurysms or ischemic stroke.
Plain-language title generated from the registry record
Registry title: Neurovascular Product Surveillance Registry
Key facts
- Where
- Beijing, Chongqing, Ji’an, Jiamusi, Kaifeng, Liaocheng, Lishui, Nanchang, Nanning, Panzhihua, Qujing, Shanghai, Taiyuan, Xi’an, Xianyang, Zhangzhou, Zhuhai, and Zhumadian, ChinaSee the 18 sites
Where in China
- Xuanwu Hospital, Capital Medical UniversityBeijing, ChinaNo longer taking part
- Chongqing University Three Gorges HospitalChongqing, ChinaNo longer taking part
- The Affiliated Hospital of Jinggangshan UniversityJi’an, ChinaNo longer taking part
- First Affiliated Hospital of Jiamusi UniversityJiamusi, ChinaNo longer taking part
- Kaifeng Central HospitalKaifeng, ChinaNo longer taking part
- Liaocheng People's HospitalLiaocheng, ChinaNo longer taking part
- Lishui Municipal Central HospitalLishui, ChinaNo longer taking part
- The Second Affiliated Hospital of Nanchang UniversityNanchang, ChinaNo longer taking part
- The Second Nanning Peoples HospitalNanning, ChinaNo longer taking part
- Panzhihua Central HospitalPanzhihua, ChinaNo longer taking part
- Qujing First Peoples HospitalQujing, ChinaNo longer taking part
- Yangpu District Central Hospital Shanghai Yangpu Hospital Tongji UniversityShanghai, ChinaNo longer taking part
- Shanxi Cardiovascular HospitalTaiyuan, ChinaNo longer taking part
- The First Affiliated Hospital of Xi'an Jiaotong UniversityXi’an, ChinaNo longer taking part
- The First Peoples Hospital of XianyangXianyang, ChinaNo longer taking part
- Zhangzhou Municipal Hospital of Fujian ProvinceZhangzhou, ChinaNo longer taking part
- Zhuhai Peoples HospitalZhuhai, ChinaNo longer taking part
- Zhumadian Central HospitalZhumadian, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medtronic Neurovascular Clinical Affairs
- Trial code
- NCT02988128
- Record updated
- 15 September 2026
- Original description
Post market surveillance registryRead full original descriptionShow less
NeuroVascular Product Surveillance Registry (PSR) Platform
Post market surveillance registry
Inclusion: Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements; Patient has, or is intended to receive or be treated with, an eligible Medtronic product; Patient is consented within the enrollment window of the therapy received, as applicable; Patient is at least 18 years of age at time of enrollment.
Exclusion: Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results; Patient is treated or intended to be treated with an eligible Medtronic Neurovascular product; Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results; Additional criteria may be required, refer to cohort-specific Addendum, as applicable, for further guidance; Patient who is, or is expected to be inaccessible for follow-up; Patient with exclusion criteria required by local law; Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study; For MDT24028 and MDT22032:; General Inclusion Criteria:; Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements; Patient is an adult per local law at time of consent. Medtronic Business Restricted This document is electronically controlled CONFIDENTIAL 056-F275 Rev F Clinical Investigation Plan Template; General Exclusion Criteria:; Patient who may be unable to complete the study follow-up; Patient with any contraindications per the applicable Instructions for Use document; Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
For MDT16056 and MDT17077.